Medtronic plc MDT recently announced late-breaking data from the global Lead Evaluation for Defibrillation and Reliability (“LEADR”) Pivotal trial at Heart Rhythm 2024. The outcome showed that the ...
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results